ATE243202T1 - Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten - Google Patents

Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten

Info

Publication number
ATE243202T1
ATE243202T1 AT96943370T AT96943370T ATE243202T1 AT E243202 T1 ATE243202 T1 AT E243202T1 AT 96943370 T AT96943370 T AT 96943370T AT 96943370 T AT96943370 T AT 96943370T AT E243202 T1 ATE243202 T1 AT E243202T1
Authority
AT
Austria
Prior art keywords
substituted
atom
pct
active ingredients
compositions containing
Prior art date
Application number
AT96943370T
Other languages
English (en)
Inventor
Eui-Hwan Cho
Sun-Gan Chung
Joong-Young Kim
Ho-Seok Kwon
Sun-Hwan Lee
Jae-Eung Lee
Jeong-Ho Joo
Byung-Chul Kim
Dong-Wook Kang
Original Assignee
Samjin Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960047458A external-priority patent/KR100197791B1/ko
Priority claimed from KR1019960047459A external-priority patent/KR100197792B1/ko
Application filed by Samjin Pharm Co Ltd filed Critical Samjin Pharm Co Ltd
Application granted granted Critical
Publication of ATE243202T1 publication Critical patent/ATE243202T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
AT96943370T 1996-02-22 1996-12-30 Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten ATE243202T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19960004189 1996-02-22
KR19960025441 1996-06-28
KR1019960047458A KR100197791B1 (ko) 1996-02-22 1996-10-22 신규 항바이러스성 6위치에 치환된 피리미딘디온호모 카보사이 클릭 뉴클레오시드 유도체 및 그의 제조방법
KR1019960047459A KR100197792B1 (ko) 1996-06-28 1996-10-22 신규 항바이러스성 2-비스 (하이드록시메틸) 사이클로프로판-1- 메틸 피리미딘디온 유도체 및 그의 제조방법
PCT/KR1996/000265 WO1997030979A1 (en) 1996-02-22 1996-12-30 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients

Publications (1)

Publication Number Publication Date
ATE243202T1 true ATE243202T1 (de) 2003-07-15

Family

ID=27483113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943370T ATE243202T1 (de) 1996-02-22 1996-12-30 Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten

Country Status (14)

Country Link
US (1) US5922727A (de)
EP (1) EP0827498B1 (de)
JP (1) JP3049095B2 (de)
CN (1) CN1092647C (de)
AT (1) ATE243202T1 (de)
AU (1) AU710490B2 (de)
BR (1) BRPI9604907B8 (de)
CA (1) CA2217026C (de)
DE (1) DE69628750T2 (de)
ID (1) ID15963A (de)
MX (1) MX9708110A (de)
RU (1) RU2138487C1 (de)
TW (1) TW494098B (de)
WO (1) WO1997030979A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
WO2000051990A1 (en) * 1999-03-04 2000-09-08 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
KR100311949B1 (ko) 1999-03-10 2001-11-02 최승주 1-[(사이클로펜트-3-엔-1-일)메틸]-5-에틸-6-(3,5-다이메틸벤조일)-2,4-피리미딘다이온의제조방법
KR20000065885A (ko) * 1999-04-10 2000-11-15 최승주 항바이러스성 피리미딘다이온 유도체 및 그 제조방법
KR101237312B1 (ko) * 2006-02-10 2013-03-04 삼진제약주식회사 피리미딘다이온 유도체를 포함하는 c형 간염의 예방 및치료용 약학 조성물
EP2044037A2 (de) * 2006-07-24 2009-04-08 Gilead Sciences, Inc. Hemmer reverser hiv-transkriptase
WO2009005693A1 (en) * 2007-06-29 2009-01-08 Gilead Sciences, Inc. Novel hiv reverse transcriptase inhibitors
AR067181A1 (es) * 2007-06-29 2009-09-30 Gilead Sciences Inc Inhibidores de transcriptasa inversa de hiv, composicion farmaceutica, uso del compuesto para preparar un medicamento, agente de combinacion farmaceutica y metodo de inhibicion de la replicacion de un retrovirus
WO2009085797A1 (en) * 2007-12-21 2009-07-09 Gilead Sciences, Inc. Processes for preparing hiv reverse transcriptase inhibitors
CN102603652A (zh) * 2011-12-27 2012-07-25 河南师范大学 5-甲酰基嘧啶碳环核苷及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730001A (en) * 1986-01-22 1988-03-08 Southern Research Institute Carbocyclic analogues of amino and azido thymidines
HU205917B (en) * 1989-09-29 1992-07-28 Mitsubishi Chem Ind Process for producing 6-substituted pyrimidine derivatives and antiviral pharmaceutical compositions containing them as active components
EP0449726B1 (de) * 1990-03-29 1997-06-11 Mitsubishi Chemical Corporation Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten
WO1993002044A1 (en) * 1991-07-22 1993-02-04 Baker Cummins Pharmaceuticals, Inc. Acyclic 6-phenylselenenyl pyrimidine nucleosides
KR950011530A (ko) * 1993-10-21 1995-05-15 도바 다다스 사이클로프로판 유도체 및 이를 함유하는 항바이러스제
KR0151811B1 (ko) * 1993-12-21 1998-10-15 강박광 신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법

Also Published As

Publication number Publication date
AU1212497A (en) 1997-09-10
CA2217026C (en) 2001-11-20
BR9604907B1 (pt) 2011-10-18
JPH10507780A (ja) 1998-07-28
DE69628750T2 (de) 2004-04-29
DE69628750D1 (de) 2003-07-24
CA2217026A1 (en) 1997-08-28
EP0827498A1 (de) 1998-03-11
RU2138487C1 (ru) 1999-09-27
AU710490B2 (en) 1999-09-23
MX9708110A (es) 1998-06-30
WO1997030979A1 (en) 1997-08-28
ID15963A (id) 1997-08-21
CN1092647C (zh) 2002-10-16
TW494098B (en) 2002-07-11
CN1182420A (zh) 1998-05-20
BR9604907A (pt) 1998-07-21
EP0827498B1 (de) 2003-06-18
BRPI9604907B8 (pt) 2016-11-08
JP3049095B2 (ja) 2000-06-05
US5922727A (en) 1999-07-13

Similar Documents

Publication Publication Date Title
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
DE59309867D1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
TW274547B (de)
HUP0300207A2 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
DK151627C (da) Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
AR004672A1 (es) Derivados de la banzo(g)quinolina, proceso para prepararlos,su utilizacion como productos farmaceuticos, las composiciones farmaceuticas que los contieneny los metodos de tratamiento de la depresion, ansiedad y desordenes bipolares que utilizan dichos compuestos.
ATE243202T1 (de) Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten
MA27197A1 (fr) Sels de tolterodine
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
FR2685918B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
NZ240051A (en) Prodrugs of sertindole; pharmaceutical compositions and preparatory processes
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
UA48942C2 (uk) Похідне 1,3-оксазин-4-ону, проміжні сполуки для одержання даного похідного, гербіцидна композиція на його основі та спосіб боротьби з бур'янами
DE69315836T2 (de) Pyrazolpyridine für die behandlung der anämie
RU97118134A (ru) Новые противовирусные гомокарбоциклические нуклеозидные производные замещенных пиримидиндионов, способы их получения и композиции, содержащие их в качестве активных ингредиентов
ATE23995T1 (de) Pyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HRP20000733B1 (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
ATE148697T1 (de) Neue benzopyranone, verfahren zu ihrer herstellung und verwendung
DE60220779D1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.
IL115085A0 (en) Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them
KR970704463A (ko) 스트렙토그라민 유도체, 이의 제조 방법 및 이를 함유하는 약학 조성물(streptogramine derivatives, preparation of same and pharmaceutical compositions containing same)
ATE29251T1 (de) Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69521895T2 (de) Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties